Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis

V. Cottin, J. Lacronique, L. Denis, P. Jaffray, C. Khouatra, R. Guelminger, D. Valeyre, H. Nunes, J. Bienvenu, B. Crestani, C. Taillé, J. F. Cordier (Lyon, Paris, Bobigny, France)

Source: Annual Congress 2011 - Rare diffuse lung diseases
Session: Rare diffuse lung diseases
Session type: Thematic Poster Session
Number: 627
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cottin, J. Lacronique, L. Denis, P. Jaffray, C. Khouatra, R. Guelminger, D. Valeyre, H. Nunes, J. Bienvenu, B. Crestani, C. Taillé, J. F. Cordier (Lyon, Paris, Bobigny, France). Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis. Eur Respir J 2011; 38: Suppl. 55, 627

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum VEGF-D and VEGFR-3 are biomarkers in lymphangioleiomyomatosis for its diagnosis and impaired pulmonary function
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Diagnostic value of linear combination of CYFRA 21-1 and carcinoembryonic antigen in malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004

The correlation between mediastinal lymphadenopathy positivity proved by mediastinoscopy and serum levels of vascular endothelial growth factor (VEGF) and carcinoembryonic antigen (CEA) in NSCLC cases
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001

Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Relationship between serum VEGF and tuberculous patients and non-tuberculousis mycobacterium patients
Source: Eur Respir J 2003; 22: Suppl. 45, 341s
Year: 2003

Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004

The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

Clinical evaluation of NSE, CYFRA 21-1, CEA and MCA at patients (pts.) with metastatic pleural effusion (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Diagnostic and prognostic significance of survivin levels in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011

Diagnostic role of d-dimer in suspected pulmonary embolism patients
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001

Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Clinical value of mediastinoscopy in the diagnosis of sarcoidosis: an analysis of 68 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 175s
Year: 2004

Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Diagnostic and prognostic value of a diagnostic CT regression model in suspected pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019

Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions
Source: Annual Congress 2008 - Pleural effusion
Year: 2008